During the past decade, Service de Chirurgie Vasculaire conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Service de Chirurgie Vasculaire" are "Heart Transplantation" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Service de Chirurgie Vasculaire" in a lesser frequency.

Most popular intervention types in "Service de Chirurgie Vasculaire" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "12 g of L-arginine glutamate during 6 weeks twice a day" (1 trials) and "Fruit juice or placebo absorption" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service de Chirurgie Vasculaire" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Service de Chirurgie Vasculaire". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Service de Chirurgie Vasculaire, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service de Chirurgie Vasculaire, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".